当前位置:首页 - 行情中心 - 森萱医药(920946) - 财务分析 - 现金流量表

森萱医药

(920946)

  

流通市值:53.39亿  总市值:53.41亿
流通股本:4.27亿   总股本:4.27亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金380,143,964.06258,716,727.94129,119,793.5488,822,885.77
  收到的税费返还140,946.1836,555.031,190.42211,319.03
  收到其他与经营活动有关的现金13,197,695.466,754,615.732,885,755.4631,219,567.3
  经营活动现金流入小计393,482,605.7265,507,898.7132,006,739.38520,253,772.1
  购买商品、接受劳务支付的现金112,416,302.7572,934,950.5938,263,140.13160,897,362.76
  支付给职工以及为职工支付的现金85,106,146.7560,450,988.0834,648,036.02112,122,170.54
  支付的各项税费43,733,657.9228,325,038.415,076,868.1547,358,011.09
  支付其他与经营活动有关的现金16,152,357.0211,597,711.124,974,347.1128,618,939.9
  经营活动现金流出小计257,408,464.44173,308,688.1992,962,391.41348,996,484.29
  经营活动产生的现金流量净额136,074,141.2692,199,210.5139,044,347.97171,257,287.81
二、投资活动产生的现金流量:
  收回投资收到的现金207,000,000150,000,00030,000,000245,000,000
  取得投资收益收到的现金1,435,394.92795,663.8760,834.763,855,326.43
  处置固定资产、无形资产和其他长期资产收回的现金净额---80,000
  收到的其他与投资活动有关的现金---44,223,322.22
  投资活动现金流入小计208,435,394.92150,795,663.8730,060,834.76293,158,648.65
  购建固定资产、无形资产和其他长期资产支付的现金6,522,124.324,216,456.812,257,726.6620,445,432.11
  投资支付的现金306,000,000228,000,000112,000,000165,000,000
  支付其他与投资活动有关的现金71,000,00071,000,000-110,000,000
  投资活动现金流出小计383,522,124.32303,216,456.81114,257,726.66295,445,432.11
  投资活动产生的现金流量净额-175,086,729.4-152,420,792.94-84,196,891.9-2,286,783.46
三、筹资活动产生的现金流量:
  取得借款收到的现金200,000---
  收到其他与筹资活动有关的现金---259,039.78
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计200,000--259,039.78
  偿还债务支付的现金---20,000,000
  分配股利、利润或偿付利息支付的现金62,968,567.662,968,567.6-70,801,128.83
  其中:子公司支付给少数股东的股利、利润3,200,0003,200,000--
  支付其他与筹资活动有关的现金1,194,635.691,134,635.69269,659.981,744,071.52
  筹资活动现金流出小计64,163,203.2964,103,203.29269,659.9892,545,200.35
  筹资活动产生的现金流量净额-63,963,203.29-64,103,203.29-269,659.98-92,286,160.57
四、汇率变动对现金及现金等价物的影响-1,223,900.33-368,779.14-27,264.021,920,250.1
五、现金及现金等价物净增加额-104,199,691.76-124,693,564.86-45,449,467.9378,604,593.88
  加:期初现金及现金等价物余额583,318,157.66583,318,157.66583,318,157.66504,713,563.78
  期末现金及现金等价物余额479,118,465.9458,624,592.8537,868,689.73583,318,157.66
补充资料:
  净利润-70,038,266.11-125,658,087.64
  资产减值准备-4,368,596.75-8,250,382.13
  固定资产和投资性房地产折旧-22,360,315.9-43,595,684.46
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-22,360,315.9-43,595,684.46
  无形资产摊销-582,160.97-1,201,335.69
  处置固定资产、无形资产和其他长期资产的损失--4,478.7-190,269.32
  固定资产报废损失---578,401.13
  公允价值变动损失--854,982.69--1,464,962.91
  财务费用--1,142,872.2--3,425,384.94
  投资损失--420,272.41--1,198,523.11
  递延所得税-136,840.82--2,141,505.08
  其中:递延所得税资产减少-28,968.45--284,972.02
    递延所得税负债增加-107,872.37--1,856,533.06
  存货的减少--7,593,142.06-17,992,507.63
  经营性应收项目的减少-8,223,198.9--17,788,879.17
  经营性应付项目的增加--6,733,774.19--4,154,485.28
  其他-3,516,475.4--85,800.88
  不涉及现金收支的投资和筹资活动金额其他项目-123,309.6-435,502.16
  现金的期末余额-458,624,592.8-583,318,157.66
  减:现金的期初余额-583,318,157.66-504,713,563.78
  现金及现金等价物的净增加额--124,693,564.86-78,604,593.88
公告日期2025-10-292025-08-292025-04-292025-04-14
审计意见(境内)标准无保留意见
TOP↑